US Stock MarketDetailed Quotes

MAIA MAIA Biotechnology

Watchlist
  • 2.750
  • -0.030-1.08%
Close Nov 1 16:00 ET
65.91MMarket Cap-1697P/E (TTM)

MAIA Biotechnology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-82.95%-4.68M
-6.73%-3.59M
-8.06%-13.07M
-35.35%-3.99M
26.90%-3.16M
-26.80%-2.56M
-19.69%-3.36M
-193.39%-12.1M
-83.53%-2.95M
-229.38%-4.32M
Net income from continuing operations
-96.29%-8.88M
-95.96%-8.07M
-25.39%-19.77M
-50.92%-6.26M
0.57%-4.88M
-36.84%-4.52M
-20.59%-4.12M
-25.37%-15.77M
-43.32%-4.15M
5.76%-4.9M
Operating gains losses
5,129.66%5.17M
20,066.09%4.18M
-108.48%-205.13K
-313.24%-63.2K
---18.19K
---102.8K
---20.94K
-102.45%-98.39K
147.42%29.64K
----
Other non cash items
--0
-92.99%11.5K
-33.45%731.66K
--48.7K
--194.63K
--324.26K
--164.07K
84.16%1.1M
--0
----
Change In working capital
-223.81%-1.39M
-182.18%-62.11K
774.78%3.09M
35.32%916.78K
205.66%971.1K
59.98%1.12M
170.44%75.58K
-68.66%352.78K
-8.51%677.5K
-453.00%-919.11K
-Change in receivables
235.31%53.81K
-76.53%-90.46K
158.80%158.41K
58.66%-16.21K
507.95%265.62K
75.91%-39.77K
---51.24K
---269.4K
---39.21K
---65.11K
-Change in prepaid assets
-137.92%-58.89K
-56.37%67.09K
156.57%285.83K
262.91%151.69K
16.42%-174.94K
326.85%155.31K
214.47%153.78K
-3,233.77%-505.23K
-571.54%-93.11K
-631.98%-209.32K
-Change in payables and accrued expense
-237.51%-1.38M
-43.72%-38.74K
134.39%2.64M
-3.52%781.3K
236.57%880.42K
48.93%1.01M
-109.43%-26.96K
-37.23%1.13M
-8.85%809.81K
-187.32%-644.69K
-Change in other current assets
----
----
--0
--0
----
----
----
110.31%322
--0
--0
Cash from discontinued investing activities
Operating cash flow
-82.95%-4.68M
-6.73%-3.59M
-8.06%-13.07M
-35.35%-3.99M
26.90%-3.16M
-26.80%-2.56M
-19.69%-3.36M
-193.39%-12.1M
-83.53%-2.95M
-229.38%-4.32M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
93.89%7.99M
4.72M
-25.70%9.27M
2,705.14%5.03M
-98.77%125.94K
3,526.25%4.12M
0
-11.09%12.48M
-115.70%-192.91K
87.10%10.26M
Net common stock issuance
41.25%8.12M
--4.99M
-18.30%11.42M
--5.67M
--0
5,649.93%5.75M
--0
143.35%13.97M
--0
114.31%11.5M
Proceeds from stock option exercised by employees
----
----
-99.69%1.43K
--0
-92.04%1.43K
----
----
-12.82%469.4K
-96.57%18.3K
--18K
Net other financing activities
---320.34K
---276.89K
-9.24%-2.15M
-203.80%-641.65K
109.89%124.51K
----
----
-710.49%-1.97M
-166.00%-211.21K
---1.26M
Cash from discontinued financing activities
Financing cash flow
93.89%7.99M
--4.72M
-25.70%9.27M
2,705.14%5.03M
-98.77%125.94K
3,526.25%4.12M
--0
-11.09%12.48M
-115.70%-192.91K
87.10%10.26M
Net cash flow
Beginning cash position
9.03%8.27M
-34.70%7.15M
3.56%10.95M
-56.59%6.1M
12.22%9.15M
-26.30%7.59M
3.56%10.95M
1,493.82%10.57M
28.41%14.06M
20.20%8.15M
Current changes in cash
111.85%3.3M
133.63%1.13M
-1,097.24%-3.8M
132.87%1.03M
-151.03%-3.03M
172.86%1.56M
-1,115.20%-3.36M
-96.16%381.07K
-730.91%-3.14M
42.38%5.94M
Effect of exchange rate changes
469.60%5.43K
-139.38%-9.49K
97.36%-117
-56.14%13.12K
61.07%-10.22K
125.14%954
7.38%-3.97K
---4.43K
--29.9K
---26.26K
End cash Position
26.60%11.58M
9.03%8.27M
-34.70%7.15M
-34.70%7.15M
-56.59%6.1M
12.22%9.15M
-26.30%7.59M
3.56%10.95M
3.56%10.95M
28.41%14.06M
Free cash flow
-82.95%-4.68M
-6.73%-3.59M
-8.06%-13.07M
-35.35%-3.99M
26.90%-3.16M
-26.80%-2.56M
-19.69%-3.36M
-193.39%-12.1M
-83.53%-2.95M
-229.38%-4.32M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -82.95%-4.68M-6.73%-3.59M-8.06%-13.07M-35.35%-3.99M26.90%-3.16M-26.80%-2.56M-19.69%-3.36M-193.39%-12.1M-83.53%-2.95M-229.38%-4.32M
Net income from continuing operations -96.29%-8.88M-95.96%-8.07M-25.39%-19.77M-50.92%-6.26M0.57%-4.88M-36.84%-4.52M-20.59%-4.12M-25.37%-15.77M-43.32%-4.15M5.76%-4.9M
Operating gains losses 5,129.66%5.17M20,066.09%4.18M-108.48%-205.13K-313.24%-63.2K---18.19K---102.8K---20.94K-102.45%-98.39K147.42%29.64K----
Other non cash items --0-92.99%11.5K-33.45%731.66K--48.7K--194.63K--324.26K--164.07K84.16%1.1M--0----
Change In working capital -223.81%-1.39M-182.18%-62.11K774.78%3.09M35.32%916.78K205.66%971.1K59.98%1.12M170.44%75.58K-68.66%352.78K-8.51%677.5K-453.00%-919.11K
-Change in receivables 235.31%53.81K-76.53%-90.46K158.80%158.41K58.66%-16.21K507.95%265.62K75.91%-39.77K---51.24K---269.4K---39.21K---65.11K
-Change in prepaid assets -137.92%-58.89K-56.37%67.09K156.57%285.83K262.91%151.69K16.42%-174.94K326.85%155.31K214.47%153.78K-3,233.77%-505.23K-571.54%-93.11K-631.98%-209.32K
-Change in payables and accrued expense -237.51%-1.38M-43.72%-38.74K134.39%2.64M-3.52%781.3K236.57%880.42K48.93%1.01M-109.43%-26.96K-37.23%1.13M-8.85%809.81K-187.32%-644.69K
-Change in other current assets ----------0--0------------110.31%322--0--0
Cash from discontinued investing activities
Operating cash flow -82.95%-4.68M-6.73%-3.59M-8.06%-13.07M-35.35%-3.99M26.90%-3.16M-26.80%-2.56M-19.69%-3.36M-193.39%-12.1M-83.53%-2.95M-229.38%-4.32M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 93.89%7.99M4.72M-25.70%9.27M2,705.14%5.03M-98.77%125.94K3,526.25%4.12M0-11.09%12.48M-115.70%-192.91K87.10%10.26M
Net common stock issuance 41.25%8.12M--4.99M-18.30%11.42M--5.67M--05,649.93%5.75M--0143.35%13.97M--0114.31%11.5M
Proceeds from stock option exercised by employees ---------99.69%1.43K--0-92.04%1.43K---------12.82%469.4K-96.57%18.3K--18K
Net other financing activities ---320.34K---276.89K-9.24%-2.15M-203.80%-641.65K109.89%124.51K---------710.49%-1.97M-166.00%-211.21K---1.26M
Cash from discontinued financing activities
Financing cash flow 93.89%7.99M--4.72M-25.70%9.27M2,705.14%5.03M-98.77%125.94K3,526.25%4.12M--0-11.09%12.48M-115.70%-192.91K87.10%10.26M
Net cash flow
Beginning cash position 9.03%8.27M-34.70%7.15M3.56%10.95M-56.59%6.1M12.22%9.15M-26.30%7.59M3.56%10.95M1,493.82%10.57M28.41%14.06M20.20%8.15M
Current changes in cash 111.85%3.3M133.63%1.13M-1,097.24%-3.8M132.87%1.03M-151.03%-3.03M172.86%1.56M-1,115.20%-3.36M-96.16%381.07K-730.91%-3.14M42.38%5.94M
Effect of exchange rate changes 469.60%5.43K-139.38%-9.49K97.36%-117-56.14%13.12K61.07%-10.22K125.14%9547.38%-3.97K---4.43K--29.9K---26.26K
End cash Position 26.60%11.58M9.03%8.27M-34.70%7.15M-34.70%7.15M-56.59%6.1M12.22%9.15M-26.30%7.59M3.56%10.95M3.56%10.95M28.41%14.06M
Free cash flow -82.95%-4.68M-6.73%-3.59M-8.06%-13.07M-35.35%-3.99M26.90%-3.16M-26.80%-2.56M-19.69%-3.36M-193.39%-12.1M-83.53%-2.95M-229.38%-4.32M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data